Author

R. T. Kundu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:yeast· 1

Frequent Co-Authors

U. Strych· 2 shared W.-H. Chen· 2 shared Z. Liu· 2 shared A. C. de Araujo Leao· 1 shared A. L. Marcinkiewicz· 1 shared B. Keegan· 1 shared B. Zhan· 1 shared C. Poveda· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

U. Strych

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivMay 24, 2022

CspZ FH-binding sites as epitopes promote antibody-mediated Lyme borreliae clearance

Y.-L. Chen, A. L. Marcinkiewicz, T. A. Nowak…·Y.-P. Lin

The paper shows that antibodies targeting CspZ FH-binding sites effectively clear Lyme borreliae in vitro and in vivo, highlighting their importance for vaccine development.

DOI 10.1128/iai.00062-22

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivNov 9, 2020

Genetic Modification to Design a Stable Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain as a COVID-19 Vaccine Candidate

W.-H. Chen, J. Wei, R. T. Kundu…·M. E. Bottazzi

The paper genetically modifies SARS-CoV-2 RBD variants in yeast to identify a more stable and manufacturable vaccine candidate.

DOI 10.1016/j.bbagen.2021.129893

yeastproteomics

𝕏 PostBluesky